|5.89||-0.3700||-5.91%||Vol 4.19M||1Y Perf 48.99%|
|Apr 19th, 2021 16:00 DELAYED|
|- -||0.01 0.17%|
|Target Price||8.13||Analyst Rating||Hold 2.75|
|Potential %||38.03||Finscreener Ranking||★★★ 49.85|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★+ 53.79|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★+ 50.74|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||1.36B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||38.88||Earnings Date||7th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||7th May 2021|
|Estimated EPS Next Report||0.48|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||3.01M|
|Avg. Monthly Volume||3.33M|
|Avg. Quarterly Volume||3.70M|
Endo International plc (NASDAQ: ENDP) stock closed at 5.89 per share at the end of the most recent trading day (a -5.91% change compared to the prior day closing price) with a volume of 4.19M shares and market capitalization of 1.36B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 3397 people. Endo International plc CEO is Blaise Coleman.
The one-year performance of Endo International plc stock is 48.99%, while year-to-date (YTD) performance is -17.97%. ENDP stock has a five-year performance of -79.28%. Its 52-week range is between 2.71 and 10.89, which gives ENDP stock a 52-week price range ratio of 38.88%
Endo International plc currently has a PE ratio of 7.90, a price-to-book (PB) ratio of 2.64, a price-to-sale (PS) ratio of 0.65, a price to cashflow ratio of 3.70, a PEG ratio of 2.32, a ROA of 1.89%, a ROC of -% and a ROE of -23.12%. The company’s profit margin is 2.00%, its EBITDA margin is 35.50%, and its revenue ttm is $2.08 Billion , which makes it $9.04 revenue per share.
Of the last four earnings reports from Endo International plc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.48 for the next earnings report. Endo International plc’s next earnings report date is 07th May 2021.
The consensus rating of Wall Street analysts for Endo International plc is Hold (2.75), with a target price of $8.13, which is +38.03% compared to the current price. The earnings rating for Endo International plc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Endo International plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Endo International plc has a Sell technical analysis rating based on Technical Indicators (ADX : 20.29, ATR14 : 0.57, CCI20 : -102.02, Chaikin Money Flow : -0.25, MACD : -0.64, Money Flow Index : 26.82, ROC : -20.51, RSI : 44.52, STOCH (14,3) : 3.23, STOCH RSI : 0.00, UO : 38.28, Williams %R : -96.77), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Endo International plc in the last 12-months were: Blaise A. Coleman (Option Excercise at a value of $0), Jack Boyle (Option Excercise at a value of $0), Mark Bradley (Option Excercise at a value of $0), Matthew J. Maletta (Option Excercise at a value of $0), Patrick Barry (Option Excercise at a value of $0), Paul V. Campanelli (Option Excercise at a value of $0), Shane M. Cooke (Sold 17 290 shares of value $149 559 ), William P. Montague (Sold 9 033 shares of value $78 406 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.